Skip to main content
大禹生物 logo

大禹生物 — Investor Relations & Filings

Ticker · 920970 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 384 across all filing types
Latest filing 2025-01-22 Earnings Release
Country CN China
Listing Beijing Stock Exchange 920970

About 大禹生物

http://www.sxdysw.cn/

Shanxi Dayu Biological Assistance Co., Ltd. specializes in the research, development, and production of advanced animal nutrition and health solutions. The company focuses on the manufacturing of feed additives, micro-ecological preparations, and biological feed products. Its core portfolio includes probiotics, enzyme preparations, and functional premixes designed to enhance livestock immunity, improve feed conversion rates, and promote sustainable farming practices. By leveraging biotechnology, the firm provides integrated solutions for the aquaculture and animal husbandry sectors, emphasizing scientific innovation and product quality to support the modernization of the agricultural supply chain.

Recent filings

Filing Released Lang Actions
2024 年年度业绩预告公告
Earnings Release Classification · 95% confidence The document is a 2024 annual performance forecast announcement for Shanxi Dayu Biological Engineering Co., Ltd. It provides preliminary financial data for the full year 2024, including expected net profit loss ranges and explanations for the performance changes. The document explicitly states that the data are preliminary, unaudited, and subject to the final audited annual report. It is a forward-looking earnings preview rather than a full financial report or audited results. The document length is short (851 characters), and it serves as an earnings forecast announcement rather than the actual earnings release or annual report. Therefore, it fits best into the Earnings Release (ER) category, which covers initial announcements of quarterly or periodical financial results or forecasts with key highlights only. FY 2024
2025-01-22 Chinese
持股5%以上股东权益变动达到1%的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a notification about a change in shareholding by a shareholder holding more than 5% of the company's shares. It details the reduction in shares held by a significant shareholder, including specific share counts and percentages before and after the change. The document explicitly mentions it is a "持股5%以上股东权益变动达到1%的提示性公告" which translates to a "Notification of change in equity of shareholders holding more than 5% reaching 1%". This matches the definition of a Major Shareholding Notification (MRQ). The document is short (1301 characters) and focuses solely on shareholding changes, not on financial results or other report types.
2025-01-21 Chinese
持股5%以上股东权益变动达到1%的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement regarding a change in shareholding by a shareholder holding more than 5% of the company's shares. It details the reduction in shares held by a significant shareholder, including specific dates, share quantities, and percentages before and after the change. The document explicitly states it is a "持股5%以上股东权益变动达到1%的提示性公告," which translates to a notification of a change in significant shareholding exceeding 1%. There is no financial report, earnings data, or management discussion. The content fits the definition of a Major Shareholding Notification (MRQ). The document length is short and focused solely on shareholding changes, confirming it is not a full report or announcement of a report publication.
2025-01-20 Chinese
关于全资孙公司完成工商注册并取得营业执照的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shanxi Dayu Bioengineering Co., Ltd. about the completion of business registration and obtaining business licenses for its wholly-owned subsidiaries. It details the establishment of new subsidiaries, their registration details, and business scope. There is no financial data, no report or presentation attached, and the document is relatively short (1190 characters). It is clearly an announcement about corporate structural changes related to new subsidiaries, not a financial report or regulatory filing. This fits best under a general regulatory announcement category rather than a specific financial report or management change. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2025-01-19 Chinese
关于与蒲县人民政府签订框架协议的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by Shanxi Dayu Bioengineering Co., Ltd. regarding the signing of a framework agreement with the Puxian People's Government for a pig integrated smart farming base project. It is a detailed announcement about the agreement's terms, rights and obligations of both parties, project description, and risk warnings. The document explicitly states it is a framework agreement and not a substantive transaction or major asset restructuring. There is no financial data, no report or financial statements, no earnings or audit information. It is a corporate announcement about a cooperation agreement and project framework, which fits best under general regulatory announcements. The document length is 3815 characters, which is relatively short and it is not a report publication announcement but a regulatory announcement of a corporate agreement. Therefore, the best classification is Regulatory Filings (RNS).
2025-01-14 Chinese
上海市锦天城律师事务所关于山西大禹生物工程股份有限公司 2025 年第一次临时股东大会的法律意见书
Regulatory Filings
2025-01-07 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.